Balanced news tone
News Sentiment
SLGL sentiment intelligence
Sol Gel Technologies Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
76/100 classification confidence.
directly relevant articles
high-authority source matches
+1.4% over one week, -3.0% over four weeks, trend active, and materially above fair value.
Sol Gel Technologies Ltd (SLGL) Earnings Forecast: Future EPS & Revenue Growth Estimates
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Sol Gel Technologies Ltd (SLGL) Earnings Forecast: Future EPS & Revenue Growth Estimates
Sol Gel Technologies Ltd (SLGL) has an earnings forecast score of 8.00 and an average analyst price target of $50.00, supported by a "Buy" trend from 3 analysts. The company's expected revenue for the next quarter is $1.20M, and analysts forecast an EPS of -$2.57 for the upcoming
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 18 Jun 2026 12:39
- Source
- TradingKey
Sol Gel Technologies Ltd (SLGL) Risk Assessment: Volatility, Financial Risk & Investment Risk
- Tone
- Negative 5/100
- Event
- Market update
- Published
- 17 Jun 2026 15:54
- Source
- TradingKey
Sol Gel Technologies Ltd (SLGL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article from TradingKey provides a revenue breakdown for Sol Gel Technologies Ltd (SLGL). However, it states that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. The page displays basic stock in
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jun 2026 08:41
- Source
- TradingKey
Sol Gel Technologies Ltd (SLGL) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of Sol Gel Technologies Ltd's (SLGL) historical dividend payouts and stock split events. It indicates that the company has not distributed any dividends in the past five years. However, it notes a stock merger event scheduled for May 1, 2025, wit
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 17 Jun 2026 08:09
- Source
- TradingKey
Sol Gel Technologies Ltd (SLGL) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Sol Gel Technologies Ltd (SLGL), listing major individual and institutional holders and their respective proportions. It also provides institutional shareholding trends over several quarters, showing changes in the number of insti
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 07:41
- Source
- TradingKey
Sol Gel Technologies Ltd (SLGL) Institutional Confidence
This article from TradingKey focuses on the institutional confidence surrounding Sol Gel Technologies Ltd (SLGL). It details the current stock price, market cap, and provides an "Institutional Confidence" score, which last updated on June 17, 2026, was 3.00 with no change. The ar
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 12:11
- Source
- TradingKey
Sol Gel Technologies Q1 Loss On US$0.1 Million Revenue Fuels Bearish Narrative
Sol-Gel Technologies (SLGL) reported a Q1 2026 revenue of US$0.1 million and a basic EPS loss of US$1.31, with net income loss of US$3.7 million. Despite a reduction in annual losses over five years, the company's Q1 loss keeps focus on the durability of this improvement. The sto
- Tone
- Negative 28/100
- Event
- Earnings
- Published
- 30 May 2026 07:10
- Source
- Sahm
TD Cowen initiates Sol Gel stock with buy on dermatology drug
TD Cowen has initiated coverage on Sol Gel Technologies Ltd. (NASDAQ:SLGL) with a "buy" rating, citing the potential of its dermatology drug SGT-610 for treating basal cell carcinomas in Gorlin syndrome patients. The firm anticipates Phase III trial data in Q4 and expects signifi
- Tone
- Positive 77/100
- Event
- Guidance
- Published
- 30 May 2026 04:09
- Source
- Investing.com
TD Cowen Initiates Sol-Gel Technologies at Buy
TD Cowen has initiated coverage on Sol-Gel Technologies (SLGL) with a Buy rating. The article also briefly mentions Unity Software's (U.US) fourth-quarter financial results, reporting revenue of $609 million and a loss of 66 cents per share. Investors are required to log in to ac
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 May 2026 15:40
- Source
- Moomoo
LifeSci Capital Maintains Sol-Gel Technologies(SLGL.US) With Buy Rating, Maintains Target Price $184
LifeSci Capital has reiterated its Buy rating for Sol-Gel Technologies (SLGL.US) and maintained its target price at $184. This indicates continued confidence in the company's financial prospects and stock performance by the investment firm.
- Tone
- Positive 73/100
- Event
- Analyst action
- Published
- 29 May 2026 10:39
- Source
- Moomoo
Sol-Gel wins 2044 patent for Gorlin syndrome gel, raises $33M
Sol-Gel (NASDAQ: SLGL) announced Q1 2026 financial results, reporting a net loss of $3.7 million and revenue of $0.1 million. The company secured a patent protecting its SGT-610 Gorlin syndrome treatment until 2044 and completed a $33.1 million underwritten offering, extending it
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 28 May 2026 16:10
- Source
- Stock Titan
Sol-Gel Technologies (NASDAQ: SLGL) trims Q1 2026 loss and strengthens cash runway
Sol-Gel Technologies reported a trimmed net loss of $3.7 million in Q1 2026, down from $8.8 million in Q1 2025, primarily due to reduced R&D expenses. The company also strengthened its cash position to $52.8 million, extending its cash runway into Q1 2028. Key developments includ
- Tone
- Positive 73/100
- Event
- Balance sheet
- Published
- 28 May 2026 12:09
- Source
- Stock Titan
Sol Gel Technologies Ltd expected to post a loss of $1.84 a share - Earnings Preview
Sol Gel Technologies Ltd (SLGL) is projected to report a loss of $1.84 per share, according to an earnings preview. This forecast comes from Refinitiv, indicating an anticipated financial setback for the company.
- Tone
- Negative 29/100
- Event
- Earnings
- Published
- 19 May 2026 12:39
- Source
- TradingView
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
LifeSci Capital Initiates Sol-Gel Technologies(SLGL.US) With Buy Rating, Announces Target Price $184
LifeSci Capital has initiated coverage on Sol-Gel Technologies (SLGL.US) with a "Buy" rating. The firm has set a price target of $184 for the company's stock. This indicates a strong positive outlook from LifeSci Capital regarding Sol-Gel Technologies' future performance.
- Tone
- Positive 72/100
- Event
- Analyst action
- Published
- 13 May 2026 14:40
- Source
- Moomoo
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Up 48.9% in April
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) saw a significant increase in short interest, rising 48.9% to 18,688 shares in April, though its days-to-cover ratio remains low at 0.2 days. Institutional ownership stands at 26.18%, with Yelin Lapidot Holdings Management Ltd. recently acq
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 29 Apr 2026 04:09
- Source
- MarketBeat
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Sol-Gel Technologies (Nasdaq:SLGL) - Stock Analysis
This report provides a stock analysis of Sol-Gel Technologies (Nasdaq:SLGL), highlighting its current market capitalization of US$236.3m and a share price of US$74.83, which analysts estimate to be 32.0% undervalued. While the company has seen significant 1-year share price growt
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Apr 2026 13:38
- Source
- Simply Wall Street
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Down 31.7% in March
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) experienced a significant 31.7% decrease in short interest during March, dropping to 12,551 shares, representing about 1.3% of shares shorted. This decline comes after the company reported a substantial quarterly miss, with EPS of ($1.07) a
- Tone
- Negative 39/100
- Event
- Earnings
- Published
- 14 Apr 2026 09:39
- Source
- MarketBeat
SLGL PE Ratio & Valuation, Is SLGL Overvalued
Sol Gel Technologies Ltd (SLGL) is currently considered undervalued, with its forward PS ratio of 0.00 significantly below its five-year average of -16.00. The fair price for SLGL is estimated to be between +Inf to +Inf based on relative valuation methods. Despite this, its curre
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 Apr 2026 17:09
- Source
- Intellectia AI
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Mar 2026 07:00
- Source
- Market source
Sol-Gel (NASDAQ: SLGL) prices $33.1M oversubscribed share offering
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Mar 2026 07:00
- Source
- Stock Titan
Here's Why We're Not At All Concerned With Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 15 Jan 2026 08:00
- Source
- simplywall.st
We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Easily Afford To Drive Business Growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 29 Dec 2025 08:00
- Source
- Market source
Revenues Not Telling The Story For Sol-Gel Technologies Ltd. (NASDAQ:SLGL) After Shares Rise 30%
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Dec 2025 08:00
- Source
- simplywall.st
With EPS Growth And More, Puma Biotechnology (NASDAQ:PBYI) Makes An Interesting Case
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 09 Dec 2025 08:00
- Source
- simplywall.st